Skip to contentS
Strata Critical Medical, Inc.
S
SRTAStrata Critical Medical, Inc. Q1 2026 · 10-Q
Revenue$67.38M$67.38M+87.4% vs Q1 2025 Net Income$2.15M$2.15MN/M vs Q1 2025 EPS Diluted$0.03$0.03N/M vs Q1 2025 Gross Profit$14,117,000+100.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Strata Critical Medical, Inc. · CIK 1779128 · Engraved from SEC EDGAR
Operating Cash Flow$3,885,000N/M Free Cash Flowderived-$1,294,000N/M Margins · derivedGross margin21.0%+1.3 pt vs Q1 2025
Operating margin-4.4%+11.4 pt vs Q1 2025
Net margin3.2%+12.9 pt vs Q1 2025
ended Mar 31, 2026 · filed May 6, 2026 · 36 d after period end